These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11333921)

  • 1. Biophysical analysis of natural variants of the multimerization region of Epstein-Barr virus lytic-switch protein BZLF1.
    Hicks MR; Balesaria S; Medina-Palazon C; Pandya MJ; Woolfson DN; Sinclair AJ
    J Virol; 2001 Jun; 75(11):5381-4. PubMed ID: 11333921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus BZLF1 gene, a switch from latency to lytic infection, is expressed as an immediate-early gene after primary infection of B lymphocytes.
    Wen W; Iwakiri D; Yamamoto K; Maruo S; Kanda T; Takada K
    J Virol; 2007 Jan; 81(2):1037-42. PubMed ID: 17079287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The bZip dimerization domain of the Epstein-Barr virus BZLF1 (Z) protein mediates lymphoid-specific negative regulation.
    Hong Y; Holley-Guthrie E; Kenney S
    Virology; 1997 Mar; 229(1):36-48. PubMed ID: 9123876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strain variation in Epstein-Barr virus immediate early genes.
    Packham G; Brimmell M; Cook D; Sinclair AJ; Farrell PJ
    Virology; 1993 Feb; 192(2):541-50. PubMed ID: 8093650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis of lytic cycle activation by the Epstein-Barr virus ZEBRA protein.
    Petosa C; Morand P; Baudin F; Moulin M; Artero JB; Müller CW
    Mol Cell; 2006 Feb; 21(4):565-72. PubMed ID: 16483937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of oriLyt, the lytic origin of DNA replication of Epstein-Barr virus, by BZLF1.
    Schepers A; Pich D; Hammerschmidt W
    Virology; 1996 Jun; 220(2):367-76. PubMed ID: 8661388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of lytic Epstein-Barr virus (EBV) infection in EBV-associated malignancies using adenovirus vectors in vitro and in vivo.
    Westphal EM; Mauser A; Swenson J; Davis MG; Talarico CL; Kenney SC
    Cancer Res; 1999 Apr; 59(7):1485-91. PubMed ID: 10197618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The BZLF1 protein of EBV has a coiled coil dimerisation domain without a heptad leucine repeat but with homology to the C/EBP leucine zipper.
    Kouzarides T; Packham G; Cook A; Farrell PJ
    Oncogene; 1991 Feb; 6(2):195-204. PubMed ID: 1847997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reactivation of Epstein-Barr virus: regulation and function of the BZLF1 gene.
    Speck SH; Chatila T; Flemington E
    Trends Microbiol; 1997 Oct; 5(10):399-405. PubMed ID: 9351176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of the BZLF1 promoter of Epstein-Barr virus by second messengers in anti-immunoglobulin-treated B cells.
    Daibata M; Speck SH; Mulder C; Sairenji T
    Virology; 1994 Feb; 198(2):446-54. PubMed ID: 8291228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A molecular link between malaria and Epstein-Barr virus reactivation.
    Chêne A; Donati D; Guerreiro-Cacais AO; Levitsky V; Chen Q; Falk KI; Orem J; Kironde F; Wahlgren M; Bejarano MT
    PLoS Pathog; 2007 Jun; 3(6):e80. PubMed ID: 17559303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional analysis of the mutated Epstein-Barr virus oncoprotein LMP1(69del): implications for a new role of naturally occurring LMP1 variants.
    Larcher C; Bernhard D; Schaadt E; Adler B; Ausserlechner MJ; Mitterer M; Huemer HP
    Haematologica; 2003 Dec; 88(12):1324-35. PubMed ID: 14687985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation of a single amino acid residue in the basic region of the Epstein-Barr virus (EBV) lytic cycle switch protein Zta (BZLF1) prevents reactivation of EBV from latency.
    Schelcher C; Valencia S; Delecluse HJ; Hicks M; Sinclair AJ
    J Virol; 2005 Nov; 79(21):13822-8. PubMed ID: 16227304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of variants in the promoter of EBV gene BZLF1 in normal donors, HIV-positive patients and in AIDS-related lymphomas.
    Martini M; Capello D; Serraino D; Navarra A; Pierconti F; Cenci T; Gaidano G; Larocca LM
    J Infect; 2007 Mar; 54(3):298-306. PubMed ID: 16784778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A concatenated form of Epstein-Barr viral DNA in lymphoblastoid cell lines induced by transfection with BZLF1.
    Cho MS; Tran VM
    Virology; 1993 Jun; 194(2):838-42. PubMed ID: 8389085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Latent and lytic Epstein-Barr virus replication strategies.
    Tsurumi T; Fujita M; Kudoh A
    Rev Med Virol; 2005; 15(1):3-15. PubMed ID: 15386591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activators of the Epstein-Barr virus lytic program concomitantly induce apoptosis, but lytic gene expression protects from cell death.
    Inman GJ; Binné UK; Parker GA; Farrell PJ; Allday MJ
    J Virol; 2001 Mar; 75(5):2400-10. PubMed ID: 11160743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B-cell polyclonal activation and Epstein-Barr viral abortive lytic cycle are two key features in acute infectious mononucleosis.
    Al Tabaa Y; Tuaillon E; Jeziorski E; Ouedraogo DE; Bolloré K; Rubbo PA; Foulongne V; Rodière M; Vendrell JP
    J Clin Virol; 2011 Sep; 52(1):33-7. PubMed ID: 21684200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One-step multiplex real-time PCR assay to analyse the latency patterns of Epstein-Barr virus infection.
    Kubota N; Wada K; Ito Y; Shimoyama Y; Nakamura S; Nishiyama Y; Kimura H
    J Virol Methods; 2008 Jan; 147(1):26-36. PubMed ID: 17870188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BZLF1 transcript variants in Epstein-Barr virus-positive epithelial cell lines.
    Needham J; Adamson AL
    Virus Genes; 2019 Dec; 55(6):779-785. PubMed ID: 31552622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.